Your Health, We Care
The most common adverse reactions in adults (incidence ≥2%) are nausea, vomiting, abdominal pain, gastrointestinal hemorrhage, anemia, and neutropenia.
The most common adverse reactions in pediatric patients (incidence ≥5%) treated with Fidaxomicin are pyrexia, abdominal pain, vomiting, diarrhea, constipation, increased aminotransferases, and rash.
FDA,2020.05
Fidaxomicinis a macrolide antibiotic developed by Optimer, which is mainly used ···【more】
Release date：2024-08-30Recommended：165
Fidaxomicinis a macrolide antibiotic developed by Optimer, which is mainly used ···【more】
Release date：2024-08-30Recommended：197
Fidaxomicin is prescribed for the management of Clostridium difficile associated···【more】
Release date：2024-08-05Recommended：193
Fidaxomicin is a pharmaceutical agent specifically indicated for the treatment o···【more】
Release date：2024-08-05Recommended：180
Fidaxomicin is a prescription medication that should be administered under the g···【more】
Release date：2024-08-05Recommended：163
Fidaxomicin is a pharmaceutical agent specifically designed to combat infections···【more】
Release date：2024-07-30Recommended：158
